Answers are grounded in this paper and cite their sources.
Dostarlimab PK parameters are similar to other anti-programmed cell death protein-1 antibodies. The clinical impact of covariates on exposure was limited-to-moderate, supporting recommended dostarlimab monotherapy therapeutic dosing.
No takes yet. Share an insight, caveat, or question.
Melhem et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: